Champions Oncology (CSBR) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.03 --0%
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q2 EPS of $0.05, $0.08 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.32 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs updates view on protein markets ahead of earnings
- H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
- Select Water Solutions signs 12-year water deal in Northern Delaware Basin
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
